Novo Integrated Sciences Inc (NVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 03-2013 | 12-2012 | 09-2012 | 08-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25 | 6 | 24 | N/A | 12 |
| TOTAL | $33 | $17 | $59 | $N/A | $56 |
| Non-Current Assets | |||||
| PPE Net | 16 | 18 | 19 | N/A | 20 |
| Other Non-Current Assets | 0 | 0 | 198 | 0 | 198 |
| TOTAL | $16 | $18 | $216 | $N/A | $218 |
| Total Assets | $49 | $35 | $275 | $N/A | $274 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 120 | 118 | 124 | 0 | 133 |
| Accrued Expenses | 40 | 26 | 23 | N/A | 20 |
| TOTAL | $204 | $242 | $214 | $N/A | $174 |
| Non-Current Liabilities | |||||
| Long Term Debt | 57 | 3 | 3 | N/A | 3 |
| Other Non-Current Liabilities | 710 | 587 | 580 | 0 | 497 |
| TOTAL | $767 | $590 | $583 | $N/A | $500 |
| Total Liabilities | $974 | $832 | $797 | $N/A | $674 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,469 | 8,444 | 6,709 | N/A | 6,709 |
| Common Shares | -136 | 69 | -145 | N/A | 67 |
| Retained earnings | -17,774 | -17,531 | -17,366 | N/A | -17,167 |
| Other shareholders' equity | -50 | -249 | 174 | 0 | -115 |
| TOTAL | $-925 | $-797 | $-522 | $N/A | $-400 |
| Total Liabilities And Equity | $49 | $35 | $275 | $0 | $274 |